Skip to main content
Journal of Cancer logoLink to Journal of Cancer
. 2025 Apr 12;16(7):2360–2361. doi: 10.7150/jca.113959

Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression: Erratum

Yong-lin Lu 1,*, Ya-bin Ma 2,*, Chan Feng 1, Dong-lei Zhu 1, Jie Liu 1, Lv Chen 1, Shu-jing Liang 1,, Chun-yan Dong 1,
PMCID: PMC12036104  PMID: 40302807

The original version of this article contained errors in Figure 7B. Specifically, three HE-stained images were incorrectly used; two images (heart and spleen) are from the DOX group, while one image (heart) is from the CYC+DOX group. These errors have now been corrected. All other images in the figure remain unchanged, and the interpretation of the results is unaffected. The authors apologize for any inconvenience this may have caused. The correct images appear below.

Figure 7.

Figure 7

Histopathological examination of tumors and organs isolated from nude mice after different treatments on day 14. (b). H&E staining of main organs.


Articles from Journal of Cancer are provided here courtesy of Ivyspring International Publisher

RESOURCES